PCN37 PRELIMINARY COST-CONSEQUENCE ANALYSIS OF EPIRUBICIN/CISPLATIN/5FU (ECF) COMPARED TO EPIRUBICIN/CISPLATIN/CAPECITABINE (ECX) IN PATIENTS WITH ADVANCED OESOPHAGOGASTRIC CANCER

✍ Scribed by AM Horgan; J Knox; G Liu; PA Bradbury; C Sahi; NB Leighl

• Book ID: 118608909
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 71 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)70215-1